Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-market Study to Evaluate Post-implant Patency Rates of the External Saphenous Vein Support (eSVS®) Mesh in the Treatment of Saphenous Vein Grafts (SVGs) During Coronary Artery Bypass Grafting (CABG) Versus SVGs Without the eSVS Mesh.

NCT01462721 is registered in ClinicalTrials.gov with Kips Bay Medical, Inc. as lead sponsor.

NCT NCT01462721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01462721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-market Study to Evaluate Post-implant Patency Rates of the External Saphenous Vein Support (eSVS®) Mesh in the Treatment of Saphenous Vein Grafts (SVGs) During Coronary Artery Bypass Grafting (CABG) Versus SVGs Without the eSVS Mesh.
Lead sponsor
Kips Bay Medical, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
October 31, 2011
Completion date
February 28, 2013
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, arteriosclerosis, cardiovascular diseases, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, vascular diseases